Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001802359 | SCV002047791 | pathogenic | Hereditary factor VIII deficiency disease | 2021-04-22 | criteria provided, single submitter | clinical testing | The F8 c.1257_1262delinsG; p.Ala420ArgfsTer2 variant, to our knowledge, is not reported in the medical literature but is reported in the CDC Hemophilia Mutation Project database (see link). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by deleting 6 nucleotides and inserting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: CDC Hemophilia Mutation Project (CHAMP & CHBMP): https://www.cdc.gov/ncbddd/hemophilia/champs.html |